These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 21398516)

  • 1. Mechanistic control of carcinoembryonic antigen-related cell adhesion molecule-1 (CEACAM1) splice isoforms by the heterogeneous nuclear ribonuclear proteins hnRNP L, hnRNP A1, and hnRNP M.
    Dery KJ; Gaur S; Gencheva M; Yen Y; Shively JE; Gaur RK
    J Biol Chem; 2011 May; 286(18):16039-51. PubMed ID: 21398516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon regulatory factor 1 and a variant of heterogeneous nuclear ribonucleoprotein L coordinately silence the gene for adhesion protein CEACAM1.
    Dery KJ; Silver C; Yang L; Shively JE
    J Biol Chem; 2018 Jun; 293(24):9277-9291. PubMed ID: 29720400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. hnRNP L and hnRNP A1 induce extended U1 snRNA interactions with an exon to repress spliceosome assembly.
    Chiou NT; Shankarling G; Lynch KW
    Mol Cell; 2013 Mar; 49(5):972-82. PubMed ID: 23394998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. hnRNP A1 contacts exon 5 to promote exon 6 inclusion of apoptotic Fas gene.
    Oh Hk; Lee E; Jang HN; Lee J; Moon H; Sheng Z; Jun Y; Loh TJ; Cho S; Zhou J; Green MR; Zheng X; Shen H
    Apoptosis; 2013 Jul; 18(7):825-35. PubMed ID: 23430061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered splicing of CEACAM1 in breast cancer: identification of regulatory sequences that control splicing of CEACAM1 into long or short cytoplasmic domain isoforms.
    Gaur S; Shively JE; Yen Y; Gaur RK
    Mol Cancer; 2008 May; 7():46. PubMed ID: 18507857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneous ribonucleoprotein m is a splicing regulatory protein that can enhance or silence splicing of alternatively spliced exons.
    Hovhannisyan RH; Carstens RP
    J Biol Chem; 2007 Dec; 282(50):36265-74. PubMed ID: 17959601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory roles of heterogeneous nuclear ribonucleoprotein M and Nova-1 protein in alternative splicing of dopamine D2 receptor pre-mRNA.
    Park E; Iaccarino C; Lee J; Kwon I; Baik SM; Kim M; Seong JY; Son GH; Borrelli E; Kim K
    J Biol Chem; 2011 Jul; 286(28):25301-8. PubMed ID: 21622564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. hnRNP A1 and secondary structure coordinate alternative splicing of Mag.
    Zearfoss NR; Johnson ES; Ryder SP
    RNA; 2013 Jul; 19(7):948-57. PubMed ID: 23704325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of hnRNP A1 alternative splicing: an intron element represses use of the common 3' splice site.
    Simard MJ; Chabot B
    Mol Cell Biol; 2000 Oct; 20(19):7353-62. PubMed ID: 10982852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of exon skipping and inclusion by heterogeneous nuclear ribonucleoprotein A1 and pre-mRNA splicing factor SF2/ASF.
    Mayeda A; Helfman DM; Krainer AR
    Mol Cell Biol; 1993 May; 13(5):2993-3001. PubMed ID: 8474457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. hnRNP A1 controls HIV-1 mRNA splicing through cooperative binding to intron and exon splicing silencers in the context of a conserved secondary structure.
    Damgaard CK; Tange TO; Kjems J
    RNA; 2002 Nov; 8(11):1401-15. PubMed ID: 12458794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The heterogeneous nuclear ribonucleoprotein L is an essential component in the Ca2+/calmodulin-dependent protein kinase IV-regulated alternative splicing through cytidine-adenosine repeats.
    Yu J; Hai Y; Liu G; Fang T; Kung SK; Xie J
    J Biol Chem; 2009 Jan; 284(3):1505-13. PubMed ID: 19017650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global identification of hnRNP A1 binding sites for SSO-based splicing modulation.
    Bruun GH; Doktor TK; Borch-Jensen J; Masuda A; Krainer AR; Ohno K; Andresen BS
    BMC Biol; 2016 Jul; 14():54. PubMed ID: 27380775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Truncated SCRIB isoform promotes breast cancer metastasis through HNRNP A1 mediated exon 16 skipping.
    Zhang B; Xie SH; Hu JY; Lei SJ; Shen LH; Liu HT; Zheng Q; Zhang ZM; Wu CL; Li Q; Wang F
    Acta Pharmacol Sin; 2023 Nov; 44(11):2307-2321. PubMed ID: 37402999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HnRNP L-mediated regulation of mammalian alternative splicing by interference with splice site recognition.
    Heiner M; Hui J; Schreiner S; Hung LH; Bindereif A
    RNA Biol; 2010; 7(1):56-64. PubMed ID: 19946215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. hnRNP A1 and the SR proteins ASF/SF2 and SC35 have antagonistic functions in splicing of beta-tropomyosin exon 6B.
    Expert-Bezançon A; Sureau A; Durosay P; Salesse R; Groeneveld H; Lecaer JP; Marie J
    J Biol Chem; 2004 Sep; 279(37):38249-59. PubMed ID: 15208309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct sets of adjacent heterogeneous nuclear ribonucleoprotein (hnRNP) A1/A2 binding sites control 5' splice site selection in the hnRNP A1 mRNA precursor.
    Hutchison S; LeBel C; Blanchette M; Chabot B
    J Biol Chem; 2002 Aug; 277(33):29745-52. PubMed ID: 12060656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hnRNP A1 protein regulates HIV-1 tat splicing via a novel intron silencer element.
    Tange TO; Damgaard CK; Guth S; Valcárcel J; Kjems J
    EMBO J; 2001 Oct; 20(20):5748-58. PubMed ID: 11598017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An intron element modulating 5' splice site selection in the hnRNP A1 pre-mRNA interacts with hnRNP A1.
    Chabot B; Blanchette M; Lapierre I; La Branche H
    Mol Cell Biol; 1997 Apr; 17(4):1776-86. PubMed ID: 9121425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneous Nuclear Ribonucleoprotein A1 (hnRNP A1) and hnRNP A2 Inhibit Splicing to Human Papillomavirus 16 Splice Site SA409 through a UAG-Containing Sequence in the E7 Coding Region.
    Zheng Y; Jönsson J; Hao C; Shoja Chaghervand S; Cui X; Kajitani N; Gong L; Wu C; Schwartz S
    J Virol; 2020 Sep; 94(20):. PubMed ID: 32759322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.